2018
DOI: 10.1371/journal.pone.0204017
|View full text |Cite
|
Sign up to set email alerts
|

Short-term effectiveness of HIV care coordination among persons with recent HIV diagnosis or history of poor HIV outcomes

Abstract: The New York City HIV Care Coordination Program (CCP) combines multiple evidence-based strategies to support persons living with HIV (PLWH) at risk for, or with a recent history of, poor HIV outcomes. We assessed the comparative effectiveness of the CCP by merging programmatic data on CCP clients with population-based surveillance data on all New York City PLWH. A non-CCP comparison group of similar PLWH who met CCP eligibility criteria was identified using surveillance data. The CCP and non-CCP groups were ma… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

5
3

Authors

Journals

citations
Cited by 23 publications
(11 citation statements)
references
References 31 publications
0
11
0
Order By: Relevance
“…The primary outcome, timely VS (TVS), is defined as VL <200 copies/mL on any VL test reported in the 6-month period following inclusion on a D2S report due to unsuppressed VL. Consistent with our prior work,62–65 those without any VL measure during follow-up will be considered not to have achieved VS, given their lack of documented clinical monitoring since their last unsuppressed VL. The 6-month follow-up period allows sufficient time to capture changes in VS status, based on US Department of Health and Human Services HIV guidelines, which reinforce the standard practice of VL monitoring every 3–4 months, or more often when adherence difficulties are apparent, and every 4–8 weeks until VS is reached, for PWH starting or changing ART regimens 66.…”
Section: Methods and Analysismentioning
confidence: 69%
“…The primary outcome, timely VS (TVS), is defined as VL <200 copies/mL on any VL test reported in the 6-month period following inclusion on a D2S report due to unsuppressed VL. Consistent with our prior work,62–65 those without any VL measure during follow-up will be considered not to have achieved VS, given their lack of documented clinical monitoring since their last unsuppressed VL. The 6-month follow-up period allows sufficient time to capture changes in VS status, based on US Department of Health and Human Services HIV guidelines, which reinforce the standard practice of VL monitoring every 3–4 months, or more often when adherence difficulties are apparent, and every 4–8 weeks until VS is reached, for PWH starting or changing ART regimens 66.…”
Section: Methods and Analysismentioning
confidence: 69%
“…It is not clear whether our trial's findings reflect a null difference in effectiveness between the revised and original CCP (which has already shown superiority to usual care 20,21,44 ) or reflect incomplete implementation of revised-CCP components during the trial. Analyses to date have not detected significant implementation variability in relation to the outcome, but our implementation measure may be insufficiently sensitive to such variability.…”
Section: Contextualization Of Null Findingsmentioning
confidence: 86%
“…The initial CCP was implemented at 28 Ryan White Part A‐funded agencies, reaching over 7000 clients in less than 4 years. The CCP demonstrated modest benefits for viral load suppression among newly diagnosed PWH and previously diagnosed but consistently unsuppressed PWH [ 10 , 14 , 15 ]. Following an outline developed by the NYC Health Department and the local Ryan White Part A Community Planning Council, refinements to the CCP were implemented in 2018 to enhance intervention delivery, engagement and impact, and to reduce implementation barriers.…”
Section: Introductionmentioning
confidence: 99%